# Preclinical

> **NIH NIH P20** · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · 2022 · $312,914

## Abstract

Project Summary: 
The Preclinical Research Core (PRC) will provide a centralized resource for investigators utilizing preclinical 
models within Pennington Biomedical Research Center’s Metabolic Basis of Disease COBRE. The PRC will 
support all aspects of animal research, including experimental design, execution of in vivo procedures, access 
and training in the use of state-of-the-art equipment for animal phenotyping, data analysis and interpretation, 
use of genetically-modified mouse lines, and general support in areas of animal health and regulatory 
compliance. The overarching goal of the PRC is to unify and extend existing resources that currently support 
preclinical research into a cohesive team that effectively mentors, trains and supports COBRE investigators. 
Considering that each of the COBRE research projects utilizes preclinical models, the mentoring, technical 
support and equipment housed within the PRC should substantially enhance the productivity and innovation of 
each research project.

## Key facts

- **NIH application ID:** 10333352
- **Project number:** 5P20GM135002-03
- **Recipient organization:** LSU PENNINGTON BIOMEDICAL RESEARCH CTR
- **Principal Investigator:** Christopher D Morrison
- **Activity code:** P20 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $312,914
- **Award type:** 5
- **Project period:** 2020-03-01 → 2025-01-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10333352

## Citation

> US National Institutes of Health, RePORTER application 10333352, Preclinical (5P20GM135002-03). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10333352. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*